Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.

导出 LinkOut

翻译打印收藏纠错

作者： Amir,Goren ^[1] ; Xianchen,Liu ; Shaloo,Gupta ; Teresa A,Simon ; Hemant,Phatak

作者单位： 1Health Outcomes Practice, Kantar Health, New York, NY; 2Global Health Economics and Outcomes Research, Pfizer Inc, New York, NY; 3Health Outcomes Practice, Kantar Health, Princeton, NJ; 4Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb, Pennington, NJ; and 5Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, NJ. ^[1]

主题词成年人(Adult);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗凝药(Anticoagulants);阿司匹林(Aspirin);心房颤动(Atrial Fibrillation);女(雌)性(Female);纤维蛋白溶解药(Fibrinolytic Agents);人类(Humans);Logistic模型(Logistic Models);男(雄)性(Male);中年人(Middle Aged);危险性评估(Risk Assessment);性别因素(Sex Factors);卒中(Stroke);美国(United States);华法林(Warfarin)

DOI 10.1097/MJT.0000000000000001

PMID 24326696

发布时间 2015-07-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

American journal of therapeutics

248-56页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.

American journal of therapeutics

相似文献

American journal of therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.

American journal of therapeutics

相似文献

American journal of therapeutics

相关期刊

检索历史清除